2022 American Transplant Congress
Post-Transplant Lymphoproliferative Disorder in Kidney and Simultaneous Pancreas and Kidney Transplant Recipients Predictors, and Patient and Allograft Outcomes
*Purpose: Post-transplant lymphoproliferative disorder (PTLD) is a devastating complication following kidney and pancreas transplantation. 12% of UNOS waitlisted candidates had previous transplant and 20% are…2021 American Transplant Congress
Post-Transplant Lymphoproliferative Disorder as a Trigger for Hemophagocytic Lymphohistiocytosis in Solid Organ Transplant – Case Series
Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Hemophagocytic Lymphohistiocytosis (HLH) is a hyperinflammatory syndrome characterized by cytokine storm from the activated reticuloendothelial system. Due to the nonspecific presentation and overlap with…2021 American Transplant Congress
Risk Factors for the Development of Posttransplant Lymphoproliferative Disorder (ptld) After Pancreas Transplantation- A Registry Analysis
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: A pancreas transplant provides patients with brittle diabetes the opportunity of good long-term metabolic control. However, it requires long-term immunosuppression with its associated risks…2020 American Transplant Congress
The FcγRIIIa-158 VV Genotype Increased the Risk of Post-Transplant Lymphoproliferative Disorder in T-Cell Depleted Kidney Transplant Recipients
1CHU Tours, Tours, France, 2CHU Limoges, Limoges, France
*Purpose: Post-transplantation lymphoproliferative disorder (PTLD) is a severe complication in organ transplant recipients. The use of T lymphocyte-depleting antibodies (TLDAb), especially rabbit TLDAb contributes to…2019 American Transplant Congress
Clinicopathologic Assessment of Monoclonal Immunoglobulin (Ig) Associated Renal Disease in the Kidney Allograft
*Purpose: Monoclonal (M)Ig-associated renal disease comprises a group of disorders caused by paraproteins. Little is known about this entity in the renal allograft, as it…2019 American Transplant Congress
Long-term Outcomes And The Feasibility Of Kidney Retransplantation In Pediatric Survivors Of Post-transplant Lymphoproliferative Disease
University of Minnesota, Minneapolis, MN
*Purpose: Post-transplant lymphoproliferative disease (PTLD) is a serious and life-threatening complication of solid organ transplantation. Long-term graft outcomes and the feasibility of kidney retransplantation in…2019 American Transplant Congress
Quantitative Epstein-Barr Virus Viral Load Monitoring in Pediatric Kidney Transplantation
*Purpose: Epstein Barr virus (EBV) belongs to the family of herpesvirus and is associated with a wide range of malignancies, including post-transplant lymphoproliferative disorder (PTLD).…2019 American Transplant Congress
Post-Transplant Lymphoproliferative Disorders in Pediatric Renal Transplant Recipients: Case Series of 5 Patients
*Purpose: Post-transplant Lymphoproliferative Disorders (PTLD) after solid organ transplantation is a complication of chronic immunosuppression (IS) and is generally associated with Epstein Barr virus (EBV)…2019 American Transplant Congress
Post-Transplant Lymphoproliferative Disorders after Living-Donor Liver Transplantation: A Retrospective Cohort Study in 1,900 Cases of Single Center Experience
*Purpose: Post-transplant lymphoproliferative disorders (PTLD) is relatively rare but the most common, life-threatening neoplasms after organ transplantation. Because of their heterogeneity from benign to malignant…2019 American Transplant Congress
Retrospective Nested Case Control Study of the Impact of Immunosuppression on Post Transplant Malignancy among Adult Heart Transplant Patients
*Purpose: Post-transplant malignancy is diagnosed in approximately 18% of heart transplant (HTx) recipients and is a leading long-term cause of death among these patients. The…
American Transplant Congress abstracts